Indicadores de obesidade e resistência à insulina: uma revisão sistemática

Palavras-chave: Circunferência da cintura, Índice de massa corporal, Obesidade, Resistência à insulina

Resumo

O objetivo deste estudo foi verificar os indicadores de obesidade associados à resistência à insulina, através de uma revisão sistemática. Dois revisores independentes realizaram uma busca nas bases de dados Medline, Pubmed, LILACS, IBECS-ES e MedCarib até abril de 2019, incluindo estudos caso-controle, coorte ou delineamento transversal, em adultos. A qualidade dos artigos foi avaliada por meio do Newcastle-Ottawa Scale. Foram adotadas as normas do PRISMA para a condução da revisão, com protocolo registrado no PROSPERO. Foram incluídos na revisão 12 artigos. Associação positiva entre indicador de obesidade e HOMA-IR foi observada em todos os estudos. O indicador de obesidade que mais esteve positivamente associado ao HOMA-IR foi o IMC, seguido da circunferência da cintura. Os indicadores de obesidade estão associados ao HOMA-IR podendo ser uma ferramenta útil no rastreio da resistência à insulina.

Biografia do Autor

Hully Cantão dos Santos, Universidade Federal Espírito Santo - UFES
Mestre, Programa de Pós Graduação em Saúde Coletiva, Universidade Federal do Espírito Santo (UFES), Vitória (ES), Brasil.
Lara Onofre Ferriani , Universidade Federal do Espírito Santo - UFES
Mestre, Programa de Pós Graduação em Saúde Coletiva, Universidade Federal do Espírito Santo (UFES), Vitória (ES), Brasil.
José Geraldo Mill, Universidade Federal do Espírito Santo - UFES
Doutor, Departamento de Fisiologia, Universidade Federal do Espírito Santo, Vitória (ES), Brasil.

Referências

1. Reaven GM. Role of insulin resistance in human disease (syndrome x): an expanded definition. Annu Rev Med. 1993; 44: 121-31.

2. Granberry MC, Fonseca VA. Insulin resistance syndrome: options for treatment. South Med J. 1999;92:2-15.

3. Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, et al. Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. J Nutr. 2001;131(2):354S‐60S.

4. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mollecular and cellular endocrinology. 2010;316:129-139.

5. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization; 2000. (WHO Technical Report Series, 894).

6. Carvalheira JBC, Saad MJA. Doenças associadas à resistência à insulina/hiperinsulinemia, não incluídas na síndrome metabólica. Arq Bras Endocrinol Metab. 2006;50(2):360-367.

7. Mlinar B, Marc J, Janez A, Pfeifer M. Molecular mechanisms of insulin resistance and associated diseases. Clinica Chimica Acta. 2007; 375(1-2):20-35.

8. Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol. 2016; 311(6):F1087-F1108.

9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostassis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28:412-9.

10. Vasques ACJ, Rosado LEFPL, Alfenas RCG, Geloneze B. Análise crítica do uso dos índices do Homeostasis Model Assessment (HOMA) na avaliação da resistência à insulina e capacidade funcional das células-β pancreáticas. Arq Bras Endocrinol Metab. 2008; 52(1):32-39.

11. De Oliveira A, Cocate PG, Hermsdorff HHM, Bressa J, De Silva MF, Rodrigues JA, et al. Waist Circumference Measures: Cutoff Analyses to Detect Obesity and Cardiometabolic Risk Factors in a Southeast Brazilian Middle-Aged Men Population--a Cross-Sectional Study. Lipids in Health and Disease. 2014; 13. 141.

12. Matos LN, Giorelli GV, Dias CB. Correlation of anthropometric indicators for identifying insulin sensitivity and resistance. Sao Paulo Med J. 2011;129(1):30-5.

13. Marcadenti A, Oliveira VG, Bertoni VM, Wittke E, Dourado LP, Souza RB, et al. Resistência à insulina e indicadores antropométricos em pacientes com síndrome coronariana aguda. Rev Bras Cardiol. 2013;26(4):259-66.

14. Jamar G, Almeida FR, Gagliardi A, Sobral MR, Ping CT, Sperandio E, et al. Evaluation of waist-to-height ratio as a predictor of insulin resistance in non-diabetic obese individuals. A cross-sectional study. Sao Paulo Med. 2017;135(5):462-8.

15. Flegal KM, Shepherd JA, Looker AC, Graubard BI, Borrud LG, Ogden CL, et al. Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr. 2009; 89:500-508.

16. Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLos Medicine. 2009;6:1-6.

17. Herzog R, Álvarez-Pasquin MJ, Díaz C, Barrio JLD, Estrada JM, Gil A. Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review. BMC Public Health. 2013;13(154):1-17.

18. Wells GA, Shea B, O'Connell D, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis [Internet] 2008 [on 17 Sept 2018].

19. Hsieh CJ, Wang PW, Chen TY, The relationship between regional abdominal fat distribution and both insulin resistance and subclinical chronic inflammation in non-diabetic adults. Diabetol Metab Syndr. 2014; 6(1):49.

20. Janssen I. Influence of age on the relation between waist circumference and cardiometabolic risk markers. Nutr Metab Cardiovasc Dis. 2009;19(3):163-169.

21. Kurniawan LB, Bahrun U, Hatta M, Arif M. Body mass, total body fat percentage, and visceral fat level predict insulin resistance better than waist circumference and body mass index in health young male adults in Indonesia. J Clin Med. 2018; 7(5):96.

22. Lacerte G, Langlois MF, Doyon M, Brown C, Carpentier AC, Hivert MF. Differential impact of changes in adiposity distribution on insulin resistance and adiponectin variations over 4 years in normal weight young adults. Horm Metab Res. 2014; 46(5):354-359.

23. Lajeunesse-Trempe F, Dufour R, du Souich P, Paquette M, Kaduka LU, Christensen DL. Anthropometric measures and their association with risk factors for cardio-metabolic diseases in Kenyan adults. Ann Hum Biol. 2018;45(6-8):486‐495.

24. Lara M, Bustos P, Amigo H, Silva C, Rona RJ. Is waist circumference a better predictor of blood pressure, insulin resistance and blood lipids than body mass index in young Chilean adults? BMC Public Health. 2012;12:638.

25. Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: An analysis of the 2007-2010 Korean National Health and Nutrition Examination Survey. PLoS One. 2019;14(3):e0212963.

26. Park K, Lee DH, Erickson DJ, Himes JH, Shikany JM, Jacobs DR Jr. Association of long-term change in waist circumference with insulin resistance. Obesity (Silver Spring). 2010;18(2):370‐376.

27. Pourshahidi LK, Wallace JM, Mulhern MS, Horigan L, Estirpe JJ, McSorley EM, et al. Indices of adiposity as predictors of cardiometabolic risk and inflammation in young adults. J Hum Nutr Diet. 2016;29(1):26‐37.

28. Sasaki R, Yano Y, Yasuma T, Onishi Y, Suzuki T, Maruyama-Furuta N, et al. Association of Waist Circumference and Body Fat Weight with Insulin Resistance in Male Subjects with Normal Body Mass Index and Normal Glucose Tolerance. Intern Med. 2016;55(11):1425‐1432.

29. Vasques ACJ, Rosado LEFPD, Rosado GP, Ribeiro RDCL, Franceschini SDCC, Geloneze B, et al. Habilidade de indicadores antropométricos e de composição corporal em identificar a resistência à insulina. Arquivos Brasileiros de Endocrinologia & Metabologia. 2009;53(1):72-79.

30. Zhang R, Dong SY, Wang F, Ma C, Zhao XL, Zeng Q, et al. Associations between Body Composition Indices and Metabolic Disorders in Chinese Adults: A Cross-Sectional Observational Study. Chin Med J (Engl). 2018;131(4):379‐388.

31. Zhang M, Hu T, Zhang S, Zhou L. Associations of Different Adipose Tissue Depots with Insulin Resistance: A Systematic Review and Meta-analysis of Observational Studies. Sci Rep. 2015;5:18495.

32. Vasques AC, Rosado L, Rosado G, Ribeiro RCD, Franceschini S, & Geloneze B. Indicadores antropométricos de resistência à insulina. Arquivos Brasileiros de Cardiologia. 2010; 95(1):e14-e23.

33. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Després JP. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr. 1993;58(4):463‐467.

34. Schorr M, Dichtel LE, Gerweck AV, Valera RD, Torrani M, Miller K, et al. Sex differences in body composition and association with cardiometabolic risk. Biol Sex Differ. 2018;9(1):28.

35. Meyer MR, Clegg DJ, Prossnitz ER, Barton M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf). 2011;203(1):259‐269.

36. Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359‐404.

37. Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715‐725.

38. Sánchez–López MDP, Cuellar–Flores I, & Dresch V. The impact of gender roles on health. Women & health. 2012;52(2):182-196.

39. Varì R, Scazzocchio B, D'Amore A, Giovannini C, Gessani S, Masella R. Gender-related differences in lifestyle may affect health status. Ann Ist Super Sanita. 2016;52(2):158‐166.

40. Goedecke JH, Evans J, Keswell D, Stimson RH, Livingstone DEW, Hayes P, et al. Reduced gluteal expression of adipogenic and lipogenic genes in black South African women is associated with obesity-related insulin resistance. J Clin Endocrinol Metab. 2011; 96(12): E2029–2033.

41. Perry AC, Martin L. Race differences in obesity and its relationship to the sex hormone milieu. Horm Mol Biol Clin Investig. 2014; 19(3): 151–161.

42. Balkau B, Deanfield JE, Després JP, Bassand JP, Fox KAA, Smith SC, et al. International day for the evaluation of abdominal obesity (IDEA): A study of waist circumference, cardiovascular disease, and diabetes mellitus in 168 000 primary care patients in 63 countries. Circulation. 2007;116:1942–51.

43. Kahn HS, Cheng YJ. Comparison of adiposity indicators associated with fasting-state insulinemia, triglyceridemia, and related risk biomarkers in a nationally representative, adult population. Diabetes Res Clin Pract. 2018;136:7‐15.

44. De Araújo APS, Bertolini SMMG, & Junior JM. Alterações morfofisiológicas decorrentes do processo de envelhecimento do sistema musculoesquelético e suas consequências para o organismo humano. Biológicas & Saúde. 2014; 4(12):22-34.

45. Fechine BRA, & Trompieri N. O processo de envelhecimento: as principais alterações que acontecem com o idoso com o passar dos anos. InterSciencePlace. 2015.

Publicado
2021-12-20
Seção
Artigos de Revisão